Analysis

The biopharmaceutical company Larimar Therapeutics enters a decisive period with two significant clinical milestones scheduled for September 2025. These events...

A significant shareholder has intensified pressure on financial technology provider WEX, moving beyond a previous "vote-no" initiative to threaten direct...

Moderna's stock remains under significant pressure despite achieving a critical regulatory milestone. The U.S. Food and Drug Administration recently granted...

Banc of California shares are poised for a period of significant volatility following a series of substantial insider transactions valued...

Centene Corporation's stock experienced significant upward momentum after the healthcare provider confirmed its 2025 earnings guidance, boosting investor confidence and...

BancFirst confronts significant regulatory challenges as its executives prepare to testify before the influential U.S. Senate Banking Committee today. The...

The cannabis producer has successfully navigated away from the immediate threat of a Nasdaq delisting, though its latest financial disclosures...

Take-Two Interactive Software is approaching a defining juncture. The release of "Borderlands 4" today represents far more than the debut...

Netflix finds itself at a pivotal juncture as conflicting developments create uncertainty for investors. The streaming giant's shares are caught...

Defense technology specialist AeroVironment has delivered a quarter of remarkable financial performance, yet investor reaction has been notably cautious. The...